# US 2026/0076911 A1 · Particles, method for producing particles, and pharmaceutical composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076911 A1
- Document ID: US20260076911A1
- Status: Published application
- Kind: A1
- Application number: 19/326,002
- Filed: 2025-09-11
- Published: 2026-03-19
- Earliest claimed: 2024-09-18
- Assignees: Etria Co., Ltd.
- Inventors: Yuichi SATO; Ryota INOUE
- Web page: https://patentgrep.com/patent/US20260076911A1

## CPC

- A61K 9/1682: {Processes}
- A61K 9/1688: {resulting in pure drug agglomerate optionally containing up to 5% of excipient}
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61K 38/43: Enzymes; Proenzymes; Derivatives thereof
- A61K 38/44: Oxidoreductases (1)
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 16/4283: {against an allotypic or isotypic determinant on Ig}
- C12Y 111/01007: Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES

## Abstract

A method for producing particles is provided. The method includes: preparing a bioactive-substance-containing liquid that includes a bioactive substance and a solvent; discharging the bioactive-substance-containing liquid as droplets; and removing the solvent from the droplets to form particles, wherein a biological activity ratio represented by {(biological activity level B/biological activity level A)×100} is 80% or greater, where the biological activity level A is a biological activity level of the bioactive substance before the preparing the bioactive-substance-containing liquid, and the biological activity level B is a biological activity level of the bioactive substance after the preparing of the bioactive-substance-containing liquid.

## Claims

### Claim 1

A method for producing particles, comprising:
preparing a bioactive-substance-containing liquid that includes a bioactive substance and a solvent;
discharging the bioactive-substance-containing liquid as droplets; and
removing the solvent from the droplets to form particles,
wherein a biological activity ratio represented by {(biological activity level B/biological activity level A)×100} is 80% or greater, where the biological activity level A is a biological activity level of the bioactive substance before the preparing the bioactive-substance-containing liquid, and the biological activity level B is a biological activity level of the bioactive substance after the preparing of the bioactive-substance-containing liquid.

### Claim 2 (depends on 1)

The method according to claim 1,
wherein external stress is not applied to the bioactive-substance-containing liquid and the droplets.

### Claim 3 (depends on 1)

The method according to claim 1,
wherein the discharging is discharging the bioactive-substance-containing liquid into a gas.

### Claim 4 (depends on 1)

The method according to claim 1,
wherein the discharging is discharging the bioactive-substance-containing liquid into a vacuum.

### Claim 5 (depends on 1)

The method according to claim 1,
wherein the discharging is discharging the bioactive-substance-containing liquid into a liquefied gas.

### Claim 6 (depends on 1)

The method according to claim 1,
wherein the discharging is discharging the bioactive-substance-containing liquid from one or more discharge holes using vibration.

### Claim 7 (depends on 1)

The method according to claim 1,
wherein the bioactive-substance-containing liquid is a water-in-oil emulsion, and
diameters of droplets of the bioactive-substance-containing liquid in the water-in-oil emulsion are 100 nm or greater and 5 μm or less.

### Claim 8 (depends on 7)

The method according to claim 7,
wherein the water-in-oil emulsion includes a surfactant having a hydrophilic-lipophilic balance of 1 or greater and 8 or less.

### Claim 9 (depends on 8)

The method according to claim 8,
wherein the surfactant is sorbitan sesquioleate.

### Claim 10 (depends on 1)

Particles produced by the method according to claim 1,
wherein the particles have a volume average particle diameter of 1 μm or greater and 50 μm or less, and
the particles have a relative span factor of 1.5 or less.

### Claim 11 (depends on 10)

The particles according to claim 10,
wherein the bioactive substance includes a protein, a nucleic acid, or both a protein and a nucleic acid.

### Claim 12 (depends on 10)

The particles according to claim 10,
wherein the bioactive substance includes an antibody, an enzyme, or both an antibody and an enzyme.

### Claim 13 (depends on 10)

The particles according to claim 10,
wherein an amount of the bioactive substance is 95 percent by mass or greater relative to a total amount of the particles.

### Claim 14 (depends on 10)

A pharmaceutical composition comprising:
the particles according to claim 10; and
a lipid.

### Claim 15 (depends on 14)

The pharmaceutical composition according to claim 14, wherein a ratio μ1/μ0 of a viscosity μ1 to a viscosity μ0 is 10 or less, where the viscosity μ1 is a viscosity of the pharmaceutical composition in which an amount of the particles is 400 mg/mL, and the viscosity μ0 is a viscosity of the pharmaceutical composition in which the amount of the particles is 0 mg/mL.

### Claim 16 (depends on 14)

The pharmaceutical composition according to claim 14,
wherein the lipid is soybean oil, olive oil, fish oil, sesame oil, canola oil, sunflower oil, castor oil, coconut oil, palm oil, corn oil, or medium-chain triglyceride.

### Claim 17 (depends on 14)

The pharmaceutical composition according to claim 14,
wherein an amount of the particles dispersed in the lipid is 1 mg/mL or greater and 500 mg/mL or less.

### Claim 18 (depends on 14)

The pharmaceutical composition according to claim 14, further comprising:
an excipient.
